Taysha Gene Therapies's total assets for Q3 2025 were $316.55M, a decrease of -5.03% from the previous quarter. TSHA total liabilities were $97.56M for the fiscal quarter, a 15.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.